Oral Inhalation of Apomorphine May Relieve "Off" Periods in PD
16th Nov 2006, 08:29 GMT
A new powdered formulation of apomorphine, administered by oral inhalation, may provide rapid relief from "off" periods for patients with Parkinson's disease, a phase 2 study suggests. Medscape Medical News Susan Jeffrey
Latest news from Medscape Neurology Headlines:
- Transparent Measures Are Essential for Coordinating and Rewarding Quality Improvement in Healthcare
- Improving Caregiver Well-being Delays Nursing Home Placement of AD Patients
- New Guideline Helps Diagnose Pediatric Status Epilepticus
- SALT 1 and 2: Tolvaptan Shows Promise in Hyponatremia
- Cognition Impaired After Bypass Surgery in Smokers
- Recognizing and Managing Stimulant Complications
- FDA Safety Changes: Prevacid NapraPAC, Epzicom, Forane
- Creatine, Minocycline May Warrant Further Study in PD
- DEFUSE Study: MRI Predicts Ischemic Stroke Outcomes
- FDA Approvals: Allegra Oral Solution, Noxafil, Mirapex